New drug tested to slow kidney damage in rare genetic disease
Disease control
Completed
This study tested whether adding an experimental drug called setanaxib to standard care could help protect kidney function in people with Alport syndrome, a rare genetic condition that damages the kidneys. Twenty patients aged 12-50 received either setanaxib or a placebo pill for…
Phase: PHASE1, PHASE2 • Sponsor: Calliditas Therapeutics AB • Aim: Disease control
Last updated Mar 12, 2026 13:50 UTC